Centre extends PLI scheme to pharma sector, investment worth Rs15 crore expected
Centre extends PLI scheme to pharma sector, investment worth Rs15 crore expected Premium Bulk drugs or active pharmaceutical ingredients (APIs) are the active raw materials used in medicines to give them their therapeutic effect. Photo: Bloomberg 1 min read Share Via Read Full Story NEW DELHI: The Union Cabinet, chaired by Prime Minister Narendra Modi, on Wednesday, approved the Production Linked Incentive (PLI) Scheme for the domestic pharmaceutical sector for financial years 2020-21 to 2028-29. About Rs15,000 crore worth of incentives will be provided under the scheme. TRENDING STORIESSee A...